LEXINGTON, Mass. and AMSTERDAM, the Netherlands, Dec. 02, 2019 (GLOBE NEWSWIRE) — uniQure N.V. (NASDAQ: QURE), a leading gene therapy company advancing transformative therapies for patients with severe medical needs, today announced that it will participate in the following upcoming conferences in December:
Piper Jaffray Healthcare Conference, December 3 – 5, New York City° Matt Kapusta, chief executive officer, will participate in a fireside chat on Tuesday, December 3, at 8:30 a.m. ET.
° Members of uniQure’s management team will also participate in one-on-one investor meetings throughout the day on Tuesday, December 3.
Bay Street News